Displaying 1-8 of 8 result(s).
| Board Name | Posts By Shawn | Post Created |
|---|---|---|
| GRCU Green Cures & Botanical Distribution Inc. | All great runs have days like today | 01/13/2015 2:20:57 PM |
| GRCU Green Cures & Botanical Distribution Inc. | The volume is there for this thing | 01/12/2015 11:47:22 PM |
| GRCU Green Cures & Botanical Distribution Inc. | 1. Strong close today 2. Selloff is | 01/02/2015 4:13:27 PM |
| GRCU Green Cures & Botanical Distribution Inc. | Expect a pop today. The sell off is | 01/02/2015 9:09:04 AM |
| GRCU Green Cures & Botanical Distribution Inc. | .0065 is resistance and if broken t | 12/21/2014 9:07:33 PM |
| GRCU Green Cures & Botanical Distribution Inc. | End of year run to .01 and then 201 | 12/21/2014 8:52:57 PM |
| GRCU Green Cures & Botanical Distribution Inc. | Nice! Sounds like they have a legit | 12/21/2014 8:32:53 PM |
| GRCU Green Cures & Botanical Distribution Inc. | Could run into new year. January/Fe | 12/21/2014 8:16:55 PM |
Recent Articles
- China's Central Bank Strategies for Sustaining Market Liquidity
- E.SUN's Climate Report: A Commitment to Nature and Sustainability
- Empowering Fintech Innovations Through Ralph Dangelmaier Scholarship
- Shimao Group Faces Liquidation Petition, Share Prices Plummet
- Praxis Precision Medicines Charts Course for Future Growth and Success
- Introducing Deye's Micro Hybrid ESS: Compact Future Power
- Global Oil Prices Surge Amid US Sanctions on Russian Exports
- Premier Investments Faces Major Setbacks Amid Retail Struggles
- Dollar Soars as Robust Jobs Data Strengthens U.S. Economy
- Analyzing Tariffs and Their Impact on the Freight Sector
- Japan and U.S. Leaders Discuss Steel Deal Concerns
- Merus and Biohaven Join Forces to Advance ADC Biotherapeutics
- Tune Therapeutics Secures Over $175M to Fuel Innovative Health Solutions
- Innovative Green Bond Initiative by NUS, Northern Trust, and UOB
- Critical Insights on Aircraft Leasing and Trade Dynamics
- Market Trends: Dollar Strengthens as Asian Stocks Dip
- Johnson & Johnson Evaluates Acquisition of Intra-Cellular
- Bezos Looks Forward to Trump’s Influence on Space Exploration
- Arowana's Achievement: A Leading Force in Impact Investing
- Exploring AI Innovations Elevating Healthcare Efficiency
- CIRCA Scientific Launches Innovative CrossWise Access System
- Japan's Wage Growth and Yen Weakness Prompt BOJ Inflation Concerns
- Natera Reports Strong Growth in 2024 Revenue and Testing Volume
- FutureMain Enhances AI Predictive Maintenance in Middle East
- Standard Chartered Faces Sanctions Over Bond Mis-Selling Issues
- Goldman Sachs Adjusts Federal Rate Cut Predictions for 2025
- Caribou Biosciences Launches Phase 1 Trial for Lupus Therapy
- Exact Sciences Reports Strong Q4 2024 Revenue Growth
- China Medical University Dominates at Taiwan National Awards
- WuXi AppTec Commits to Sustainable Pharmaceutical Practices
- Rising Oil Prices as US Sanctions Impact Russian Exports
- Insignia Financial Ltd's Bidding War Escalates with Bain Capital
- Market Outlook: Earnings and Inflation Influence Stock Trends
- Celebrating Literary Excellence: PenCraft Book Awards 2024
- Challenges of Air Travel Growth in Achieving Climate Goals
- Cellectar Biosciences Unveils 2025 Strategic Vision
- Castle Biosciences Reports Strong Growth in 2024 Performance
- Telix Expands Its Pipeline with Acquisition of ImaginAb Assets
- Ascendis Pharma's Strategic Roadmap and Milestones for Growth
- Market Outlook: Job Data Fuels Bond Yields, Impacts Stocks
- Ascendis Pharma Unveils Strategic Roadmap for Future Growth
- Telix Pharmaceuticals Strengthens Position with Key Acquisition
- Innovative Retail Tech Recognized in Upcoming NRF Report
- Revvity's Upcoming Earnings Call and Positive Financial Outlook
- Vertex Pharmaceuticals Unveils Key Pipeline Developments Ahead of Meetings
- Class Action Lawsuit Against Capri Holdings Limited: Join Now
- Opportunity for Investors in Caribou Biosciences, Inc. Lawsuit
- Enhanced Offer by Bain Capital Targets Insignia Financial's Future
- Amicus Therapeutics Announces Unprecedented Revenue Growth
- Exelixis Reveals 2024 Financial Performance and 2025 Outlook